Leadership & Pay ·
Jason O'Byrne, Executive Vice President and Chief Financial Officer, will step down from Vir Biotechnology, Inc.…
VIRVir Biotechnology, Inc.
Jason O'Byrne, Executive Vice President and Chief Financial Officer, will step down from Vir Biotechnology, Inc. effective August 3, 2026, to pursue another opportunity. Brent Sabatini, current Senior Vice President and Chief Accounting Officer, has been appointed as interim principal financial officer effective August 3, 2026. Vir Biotechnology, Inc. is a biotechnology company focused on developing and commercializing infectious disease therapies.